Hepatocellular carcinoma (HCC) is one of most common causes of cancer death worldwide.
MicroRNA (miRNA) replacement gene therapy is a novel approach for HCC management …

Therapeutic strategy based on the restoration of tumor suppressor‐microRNAs (miRNAs) is
a promising approach for cancer therapy, but the low delivery efficiency of miRNA remains a …

Liver metastases from colorectal cancer (CRC) are the major cause of cancer-related deaths
in CRC patients. In our previous study, microRNA-214 (miR-214) was identified in CRC …

MiR-375 is a tumor suppressor miRNA that is downregulated in hepatocellular carcinoma
(HCC). However, due to the lack of effective delivery strategies, miR-375 replacement as a …

Hepatocellular carcinoma (HCC) poses a great threat to human health. The elegant
combination of gene therapy and chemotherapy by nanocarriers has been repeatedly …

Abstract Background Therapeutic microRNAs (miRNAs) delivery holds a lot of promise for
treating human malignancies. So, this study was carried out to examine the potential of miR …

Numerous microRNAs (miRNAs) have been demonstrated to be downregulated or
upregulated in hepatocellular carcinoma (HCC) and play important roles in its occurrence …

Targeted therapy based on adjustment of microRNA (miRNA) s activity takes great promise
due to the ability of these small RNAs to modulate cellular behavior. However, the efficacy of …

In the present research, a tumor-targeted gene carrier, PPP, was constructed through the
modification of phenylboronic acid onto the surface of a polyamidoamine dendrimer, and …

Background: Circular RNA (circRNA) can regulate the progression of hepatocellular
carcinoma (HCC). However, the role and potential mechanism of circ_0004913 in HCC are …